Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 2/20 | 0.48 |
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28638896 | 1.00 | HTR1D (0.48) | HTR1DNISCHMAOAMAOBFAAH | |
| SCHEMBL16305 | 1.00 | HTR1D (0.48) | HTR1DNISCHMAOAMAOBFAAH | |
| Hydrochloric Acid SCHEMBL1230861 | 1.00 | HTR1D (0.48) | HTR1DNISCHMAOAMAOBFAAH | |
| SCHEMBL10623832 | 1.00 | HTR1D (0.48) | HTR1DNISCHMAOAMAOBFAAH | |
| Phosphoric Acid SCHEMBL8585404 | 0.92 | HTR1D (0.42) | HTR1DEPHX2 | |
| SCHEMBL1626311 | 0.90 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBADRA2B | |
| SCHEMBL15561019 | 0.90 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBADRA2B | |
| SCHEMBL5680179 | 0.90 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBADRA2B | |
| SCHEMBL107099 | 0.90 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBADRA2B | |
| SCHEMBL7756299 | 0.90 | HTR1D (0.56) | HTR1DNISCHMAOAMAOBADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130130953-A1 | WATER RESISTANT GREASE COMPOSITION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-05-23 | — | — | US | claimed |
| US-10676689-B2 | Grease compositions for low temperature operation | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2020-06-09 | — | — | US | disclosed |
| US-20190203150-A1 | GREASE COMPOSITIONS FOR LOW TEMPERATURE OPERATION | EXXONMOBIL RES & ENG CO (US) | 2019-07-04 | — | — | US | disclosed |
| EP-2776541-A1 | WATER RESISTANT GREASE COMPOSITION | ExxonMobil Research and Engineering Company (US) | 2014-09-17 | — | — | EP | disclosed |
| US-20130130953-A1 | WATER RESISTANT GREASE COMPOSITION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-05-23 | — | — | US | disclosed |
| WO-2013070588-A1 | WATER RESISTANT GREASE COMPOSITION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-05-16 | — | — | WO | disclosed |
| US-7749523-B2 | Emollient skin conditioning cream and method | CRABTREE & EVELYN, LTD. (US) | 2010-07-06 | — | — | US | disclosed |
| US-20030133900-A1 | Emollient skin conditioning cream and method | MAYBANK INVESTMENT BANK BERHAD (MY) | 2003-07-17 | — | — | US | disclosed |
| WO-2003026607-A2 | EMOLLIENT SKIN CONDITIONING CREAM AND METHOD | CRABTREE & EVELYN, LTD. (US) | 2003-04-03 | — | — | WO | disclosed |
| US-4544756-A | INTEGRATED CIRCUITS | DRESSER INDUSTRIES, INC. (US) | 1985-10-01 | — | — | US | disclosed |
| US-4185098-A | (COCO-AMINO)ALKYL PHOSPHONATE INNER SALT AND N,N-DIMETHYL-N-(3-LAUROYLAMIDOPROPYL)AMINE | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-01-22 | — | — | US | disclosed |
| US-4085134-A | ANTISCALING, CORROSION RESISTANCE, CHELATING AGENTS | PETROLITE CORPORATION (US) | 1978-04-18 | — | — | US | disclosed |
| US-3954647-A | 1-HYDROXYETHYL-2-FATTY ACID IMIDAZOLINE HYDROCARBON OR HALOHYDROCARBON SOLVENT | ANSCOTT CHEMICAL INDUSTRIES, INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030133900-A1 | Emollient skin conditioning cream and method | CUTA, CD69, C9 | HTR1D 585/4885NISCH 2946/4885MAOA 2404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.